marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Iovance Biotherapeutics Balance Sheet 2011-2024 | IOVA
Annual Balance Sheet Iovance Biotherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-40 M | -147 M | -7.7 M | -15.7 M | -2.47 M | -82.2 M | -145 M | -107 M | -13.6 M | -44.9 M | -19.7 M | 6.48 M | 4.49 M |
Long Term Debt |
67.1 M | 71.9 M | 65.5 M | 45.4 M | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
7.78 M | 12.6 M | 5.06 M | 6.28 M | 7.25 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
85.4 M | 72.9 M | 66.5 M | 57.1 M | 6.6 M | 230 K | - | - | - | - | - | - | - |
Total Current Liabilities |
110 M | 91.5 M | 89.2 M | 54.9 M | 39.1 M | 14.4 M | 9.89 M | 4.97 M | 1.63 M | 1.66 M | 2.27 M | 11.3 M | 13.3 M |
Total Liabilities |
196 M | 164 M | 156 M | 112 M | 45.7 M | 14.6 M | 9.89 M | 4.97 M | 1.63 M | 1.66 M | 2.27 M | 11.3 M | 13.3 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.01 B | -1.57 B | -1.17 B | -830 M | -571 M | -373 M | -249 M | -157 M | -104 M | -76.6 M | -64.5 M | -30.7 M | -27.4 M |
Total Assets |
780 M | 664 M | 777 M | 768 M | 345 M | 481 M | 155 M | 172 M | 106 M | 46.5 M | 19.9 M | 29.4 K | 568 K |
Cash and Cash Equivalents |
115 M | 232 M | 78.2 M | 67.3 M | 14 M | 82.2 M | 145 M | 107 M | 33.6 M | 44.9 M | 19.7 M | - | 510 K |
Book Value |
585 M | 500 M | 622 M | 656 M | 299 M | 466 M | 145 M | 167 M | 104 M | 44.8 M | 17.6 M | -11.3 M | -12.8 M |
Total Shareholders Equity |
585 M | 500 M | 622 M | 656 M | 299 M | 466 M | 145 M | 167 M | 104 M | 44.8 M | 17.6 M | -11.3 M | -12.8 M |
All numbers in USD currency
Quarterly Balance Sheet Iovance Biotherapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
66.4 M | 69.2 M | 72.3 M | 67.1 M | 68 M | 68.8 M | 69.6 M | 71.9 M | 71.9 M | - | 71.2 M | 65.5 M | 64.7 M | 46.8 M | 47.1 M | 45.4 M | 45.4 M | 45.4 M | 45.4 M | 4.25 M | 4.25 M | 4.25 M | 4.25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
99.6 M | 102 M | 107 M | 85.4 M | 87.4 M | 90.1 M | 70.6 M | 72.9 M | 72.9 M | - | 72.2 M | 66.5 M | 65.7 M | 47.8 M | 48.1 M | 57.1 M | 57.1 M | 57.1 M | 57.1 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 230 K | 230 K | 230 K | 230 K | 297 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
218 M | 196 M | 190 M | 196 M | 178 M | 179 M | 158 M | 164 M | 152 M | - | 149 M | 156 M | 130 M | 108 M | 103 M | 112 M | 112 M | 112 M | 112 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 9.89 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.31 B | -2.22 B | -2.13 B | -2.01 B | -1.9 B | -1.78 B | -1.68 B | -1.57 B | -1.46 B | - | -1.26 B | -1.17 B | -1.07 B | -987 M | -906 M | -830 M | -830 M | -830 M | -830 M | -571 M | -571 M | -571 M | -571 M | -373 M | -373 M | -373 M | -373 M | -249 M | -249 M | -249 M | -249 M | -157 M | -157 M | -157 M | -157 M | -104 M | -104 M | -104 M | -104 M | -76.6 M | -76.6 M | -76.6 M | -76.6 M | -64.5 M | -64.5 M | -64.5 M | -64.5 M | -30.7 M | -30.7 M | -30.7 M | -30.7 M | -27.4 M | -27.4 M | -27.4 M | -27.4 M |
Total Assets |
991 M | 964 M | 870 M | 780 M | 852 M | 757 M | 825 M | 664 M | 546 M | - | 701 M | 777 M | 829 M | 853 M | 751 M | 768 M | 768 M | 768 M | 768 M | 345 M | 345 M | 345 M | 345 M | 481 M | 481 M | 481 M | 481 M | 155 M | 155 M | 155 M | 155 M | 172 M | 172 M | 172 M | 172 M | 106 M | 106 M | 106 M | 106 M | 46.5 M | 46.5 M | 46.5 M | 46.5 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 29.4 K | 29.4 K | 29.4 K | 29.4 K | 568 K | 568 K | 568 K | 568 K |
Cash and Cash Equivalents |
164 M | 229 M | 134 M | 115 M | 268 M | 230 M | 543 M | 232 M | 118 M | 108 M | 92.4 M | 78.2 M | 58.6 M | 82.8 M | 132 M | 67.3 M | 67.3 M | 67.3 M | 67.3 M | 14 M | 14 M | 14 M | 14 M | 82.2 M | 82.2 M | 82.2 M | 82.2 M | 145 M | 145 M | 145 M | 145 M | 107 M | 107 M | 107 M | 107 M | 33.6 M | 33.6 M | 13.6 M | 13.6 M | 44.9 M | 44.9 M | 44.9 M | 44.9 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | - | - | 15.5 K | - | 510 K | 510 K | 510 K | 510 K |
Book Value |
773 M | 769 M | 680 M | 585 M | 674 M | 579 M | 667 M | 500 M | 394 M | - | 552 M | 622 M | 698 M | 744 M | 647 M | 656 M | 656 M | 656 M | 656 M | 299 M | 299 M | 299 M | 299 M | 466 M | 466 M | 466 M | 466 M | 145 M | 155 M | 155 M | 155 M | 172 M | 172 M | 172 M | 172 M | 106 M | 106 M | 106 M | 106 M | 46.5 M | 46.5 M | 46.5 M | 46.5 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 29.4 K | 29.4 K | 29.4 K | 29.4 K | 568 K | 568 K | 568 K | 568 K |
Total Shareholders Equity |
773 M | 769 M | 680 M | 585 M | 674 M | 579 M | 667 M | 500 M | 394 M | 473 M | 552 M | 622 M | 698 M | 744 M | 647 M | 656 M | 656 M | 656 M | 656 M | 299 M | 299 M | 299 M | 299 M | 466 M | 466 M | 466 M | 466 M | 145 M | 145 M | 145 M | 145 M | 167 M | 167 M | 167 M | 167 M | 104 M | 104 M | 104 M | 104 M | 44.8 M | 44.8 M | 44.8 M | 44.8 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | -11.3 M | -11.3 M | -11.3 M | -11.3 M | -12.8 M | -12.8 M | -12.8 M | -12.8 M |
All numbers in USD currency